Literature DB >> 18660703

Novel roles of OX40 in the allograft response.

Gulcin Demirci1, Xian Chang Li.   

Abstract

PURPOSE OF REVIEW: In the past few years, much effort has been focused on the identification of new pathways, new mechanisms, and new therapeutic targets in transplant models. Understanding of T-cell costimulatory molecules remains one of the highly contested areas of research. In this review, we will focus specifically on OX40, and summarize the latest developments on the role of OX40 in transplant models. RECENT
FINDINGS: OX40 regulates multiple aspects of the T-cell response; it delivers a potent costimulatory signal to T effector cells and plays a key role in their survival and proliferation. OX40 also supports the transition of activated T effector cells to memory T cells. Importantly, OX40 signaling inhibits the suppressor functions of forkhead box P3 T regulatory cells and also blocks the induction of new forkhead box P3 T regulatory cells from activated T effector cells. These new findings may have major clinical implications in the induction of transplant tolerance.
SUMMARY: The current belief is that tolerance to organ transplants involves the apoptotic deletion of T effector cells and the expansion of graft-protective T regulatory cells. Given our recent understanding of OX40, we believe that targeting the OX40 costimulation is therapeutically important in the induction of transplant tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18660703     DOI: 10.1097/MOT.0b013e3282f3def3

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  8 in total

Review 1.  Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.

Authors:  Alberto Sánchez-Fueyo; Terry B Strom
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

2.  Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts.

Authors:  Cheguevara Afaneh; Thangamani Muthukumar; Michelle Lubetzky; Ruchuang Ding; Catherine Snopkowski; Vijay K Sharma; Surya Seshan; Darshana Dadhania; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

3.  Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.

Authors:  Eun Jee Kim; Jae Geun Lee; Joon Ye Kim; Seung Hwan Song; Dong Jin Joo; Kyu Ha Huh; Myoung Soo Kim; Beom Seok Kim; Yu Seun Kim
Journal:  Immunology       Date:  2017-08-23       Impact factor: 7.397

Review 4.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

Review 5.  Impact of Immune-Modulatory Drugs on Regulatory T Cell.

Authors:  Akiko Furukawa; Steven A Wisel; Qizhi Tang
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

6.  OX40L/OX40 Signal Promotes IL-9 Production by Mucosal MAIT Cells During Helicobacter pylori Infection.

Authors:  Siqi Ming; Mei Zhang; Zibin Liang; Chunna Li; Jianzhong He; Peiyu Chen; Shunxian Zhang; Xiaoli Niu; Shimei Deng; Lanlan Geng; Guoliang Zhang; Sitang Gong; Yongjian Wu
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

7.  OX40 signaling favors the induction of T(H)9 cells and airway inflammation.

Authors:  Xiang Xiao; Savithri Balasubramanian; Wentao Liu; Xiufeng Chu; Haibin Wang; Elizabeth J Taparowsky; Yang-Xin Fu; Yongwon Choi; Matthew C Walsh; Xian Chang Li
Journal:  Nat Immunol       Date:  2012-07-29       Impact factor: 25.606

Review 8.  The Costimulatory Pathways and T Regulatory Cells in Ischemia-Reperfusion Injury: A Strong Arm in the Inflammatory Response?

Authors:  Laura de Ramon; Jordi Guiteras; Roser Guiteras; Josep M Cruzado; Josep M Grinyó; Juan Torras
Journal:  Int J Mol Sci       Date:  2018-04-25       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.